Efficacy of homoharringtonine-based induction regimen in acute myeloid leukemia (AML) with double-mutated CCAAT/enhancer-binding protein alpha (CEBPA): A prospective multicenter, single-arm trial
Efficacy of homoharringtonine-based induction regimen in acute myeloid leukemia (AML) with double-mutated CCAAT/enhancer-binding protein alpha (CEBPA): A prospective multicenter, single-arm trial
Enhancer provides a potential target for ‘undruggable’ MYC in pediatric medulloblastoma - EurekAlert!
Enhancer-driven epigenetic rewiring in CBFA2T3-GLIS2 pediatric leukemia - EurekAlert!
